Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm CyTOF XT

Fluidigm has launched CyTOF XT, the fourth generation of the company's CyTOF mass cytometry platform. The instrument offers a new level of automation through streamlined operation, automatic monitoring, and easier system management, according to the company's website. It features a chilled sample carousel that cools samples to between 4° and 8° C and holds 12 5-mL and one 15-mL sample tube. The platform can acquire up to 13 different samples and panels in a single batch run, and features automated resuspension of sample pellets and addition of normalization beads. Fluidigm noted that other features include easy daily setup, automated system tuning, and real-time signal optimization. The company also noted that the system offers a high level of data quality, with minimal to no background signal seen in detection channels; and no signal compensation or deconvolution required after data collection.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.